A subcellular fractionation location assay found DLGAP1-AS1 to be primarily expressed in glioma cell cytoplasm (Figure 4A), highlighting the potential role of this molecule as a ceRNAs. The gene discussed is DLGAP1; the disease is central nervous system cancer.